Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus
- 21 December 2002
- journal article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 17 (1), 1-6
- https://doi.org/10.1016/s1056-8727(02)00181-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complicationsDiabetic Medicine, 2000
- Role of vascular endothelial growth factor in diabetic vascular complicationsKidney International, 2000
- Role of vascular endothelial growth factor in diabetic nephropathyKidney International, 2000
- Deciphering diabetic nephropathy: progress using genetic strategiesCurrent Opinion in Nephrology and Hypertension, 2000
- Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor geneHuman Immunology, 1999
- Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetesDiabetes, 1999
- Nephropathy in Type 1 Diabetes: the Role of Genetic FactorsDiabetic Medicine, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Vascular permeability factor mRNA and protein expression in human kidneyKidney International, 1992